Real-time enrollment status for this advanced malignant solid tumor clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 9:21 AM UTC
| NCT Number | NCT07293754 |
| Recruiting Status | Recruiting |
| Condition | Advanced Malignant Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Repertoire Immune Medicines |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 18, 2026: Clinical trial NCT07293754 is currently recruiting participants. This phase1 study for advanced malignant solid tumor is actively seeking new participants at 3 locations across the United States. The study is sponsored by Repertoire Immune Medicines. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07293754 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07293754 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.